The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Flatiron Health
Real world outcomes of metastatic pancreatic cancer (mPC) patients (pts) treated with liposomal irinotecan (nal-IRI) in the US.
 
Afsaneh Barzi
Consulting or Advisory Role - bioTheranostics; Merrion
 
Rebecca Miksad
No Relationships to Disclose
 
Andy Surinach
Employment - Genesis Research
 
Frank A. Corvino
Employment - Genesis Research
 
Siqi Wang
Employment - Genesis Research
 
Aracelis Z. Torres
Employment - Flatiron Health
 
Khalid Kevin Mamlouk
Employment - Merrimack
Stock and Other Ownership Interests - Agios; Blueprint Medicines; Clovis Oncology; Jounce Therapeutics; Merrimack
Consulting or Advisory Role - Blue Earth Diagnostics; Blueprint Medicines; Ipsen
 
Sonia J. Pulgar
Employment - Ipsen
 
Tanios S. Bekaii-Saab
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Bristol-Myers Squibb (Inst); Celgene; Genentech/Roche; Glenmark; Ipsen (Inst); Lilly; Lilly; Merrimack; NCCN; Regeneron; Research to Practice
Research Funding - NCCN; NCI; Oncolytics
Expert Testimony - Helsinn Therapeutics
Other Relationship - ARMO BioSciences; Exelixis; Exelixis; Merck; Polaris; Sillajen